Stimu-Let 2.5 mg Tablet

Stimu-Let 2.5 mg Tablet contains letrozole 2.5 mg, an aromatase inhibitor used mainly for hormone-sensitive breast cancer. It is an oral tablet prescribed according to the treatment plan of the oncologist. Letrozole reduces estrogen production, helping slow the growth of estrogen-dependent cancer cells.

BUY NOW

Stimu-Let 2.5 mg Tablet is primarily used for hormone receptor-positive breast cancer in postmenopausal women. Letrozole works by inhibiting the aromatase enzyme, which lowers estrogen levels and reduces hormonal stimulation of certain breast cancer cells. The medicine may also be used in selected fertility-related treatment under specialist supervision. The dosage and treatment duration should be determined by the treating healthcare professional based on the patient’s condition and response.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route Oral
Pack Size 5 Tablets in 1 Strip
Manufacturer Corona Remedies Pvt Ltd

Product Also Known As

Stimu-Let 2.5 mg Tablet, Stimu Let 2.5 mg Tablet, Stimu-Let Letrozole Tablet, Letrozole 2.5 mg Tablet, Letrozole Breast Cancer Tablet, Letrozole Aromatase Inhibitor Tablet